Cargando…

Significance of Immunogenic Cell Death-Related Prognostic Gene Signature in Cervical Cancer Prognosis and Anti-Tumor Immunity

BACKGROUND: Immunogenic cell death (ICD) can reshape the immune microenvironment of tumors. Driven by stressful pressure, by directly destroying tumor cells and activating the body’s adaptive immunity, ICD acts as a modulator of cell death, enabling the body to generate an anti-tumor immune response...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Shan, Cui, Zhaolei, Zheng, Jianfeng, Wu, Qiaoling, Yu, Haijuan, You, Yiqing, Zheng, Chaoqiang, Sun, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218566/ https://www.ncbi.nlm.nih.gov/pubmed/37250106 http://dx.doi.org/10.2147/JIR.S410140

Ejemplares similares

FBXO5 acts as a novel prognostic biomarker for patients with cervical cancer
por: Jiang, Shan, et al.
Publicado: (2023)

Performance of a PLK1‐based immune risk model for prognosis and treatment response prediction in breast cancer
por: Chen, Yan, et al.
Publicado: (2023)

Construction and comprehensive analysis of a curoptosis-related lncRNA signature for predicting prognosis and immune response in cervical cancer
por: Liu, Li, et al.
Publicado: (2023)

Subtype and prognostic analysis of immunogenic cell death-related gene signature in prostate cancer
por: Kang, Zhen, et al.
Publicado: (2023)

Comprehensive analysis of the immunogenic cell death-related signature for predicting prognosis and immunotherapy efficiency in patients with lung adenocarcinoma
por: Cui, Yingshu, et al.
Publicado: (2023)

Identification of immunogenic cell death‑related prognostic signatures in pancreatic cancer
por: Yu, Wenjing, et al.
Publicado: (2023)

A novel immunogenic cell death signature for the prediction of prognosis and therapies in glioma
por: Zhang, Jianhua, et al.
Publicado: (2023)

Construction of immunogenic cell death-related molecular subtypes and prognostic signature in colorectal cancer
por: Yu, Chun, et al.
Publicado: (2023)

Prognostic and immunotherapeutic significance of immunogenic cell death-related genes in colon adenocarcinoma patients
por: Xu, Jun, et al.
Publicado: (2023)

Identification of significant genes signatures and prognostic biomarkers in cervical squamous carcinoma via bioinformatic data
por: He, Yunan, et al.
Publicado: (2020)

Genomic analysis of immunogenic cell death-related subtypes for predicting prognosis and immunotherapy outcomes in glioblastoma multiforme
por: Liu, Zhiye, et al.
Publicado: (2023)

Identification of Immunogenic Cell-Death-Related Subtypes and Development of a Prognostic Signature in Gastric Cancer
por: Gan, Xuejun, et al.
Publicado: (2023)

Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma
por: Hu, Yuanyuan, et al.
Publicado: (2022)

Identification of immunogenic cell death-related signature on prognosis and immunotherapy in kidney renal clear cell carcinoma
por: Jiang, Silin, et al.
Publicado: (2023)

A novel immunogenic cell death–related subtype classification and risk signature for predicting prognosis and immunotherapy efficacy in gastric cancer
por: Dong, Bingqi, et al.
Publicado: (2023)

Intratumoral levels and prognostic significance of Fusobacterium nucleatum in cervical carcinoma
por: Huang, Shu-Ting, et al.
Publicado: (2020)

Identification of pyroptosis-related signature for cervical cancer predicting prognosis
por: Zhou, Cankun, et al.
Publicado: (2021)

Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma
por: Cai, Jiayang, et al.
Publicado: (2022)

The integrated single-cell analysis developed an immunogenic cell death signature to predict lung adenocarcinoma prognosis and immunotherapy
por: Zhang, Pengpeng, et al.
Publicado: (2023)

Significance of immunogenic cell death-related genes in prognosis prediction and immune microenvironment landscape of patients with cutaneous melanoma
por: Fu, Weijiang, et al.
Publicado: (2022)

Comprehensive analysis of mutational profile and prognostic significance of complex glandular pattern in lung adenocarcinoma
por: Bai, Jinsong, et al.
Publicado: (2022)

Development of an immunogenic cell death prognostic signature for predicting clinical outcome and immune infiltration characterization in stomach adenocarcinoma
por: Liu, Ye, et al.
Publicado: (2023)

Significance Analysis of Prognostic Signatures
por: Beck, Andrew H., et al.
Publicado: (2013)

Prognostic Significance of Alternative Splicing Genes in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma
por: Wang, Xiaoyu, et al.
Publicado: (2021)

Calreticulin—Multifunctional Chaperone in Immunogenic Cell Death: Potential Significance as a Prognostic Biomarker in Ovarian Cancer Patients
por: Kielbik, Michal, et al.
Publicado: (2021)

Immune-Related Four-lncRNA Signature for Patients with Cervical Cancer
por: Zheng, Jianfeng, et al.
Publicado: (2020)

Immunogenic Cell Death (ICD)-Related Gene Signature Could Predict the Prognosis of Patients with Diffuse Large B-Cell Lymphoma
por: Ping, Liqin, et al.
Publicado: (2022)

Identification of Significant Gene Signatures and Prognostic Biomarkers for Patients With Cervical Cancer by Integrated Bioinformatic Methods
por: Li, Xiaofang, et al.
Publicado: (2018)

Immunogenic cell death-related classifications guide prognosis and immunotherapy in osteosarcoma
por: Zong, Yuan, et al.
Publicado: (2023)

Construction and comprehensive analysis of a novel prognostic signature associated with immunogenic cell death molecular subtypes in patients with bladder cancer
por: Gu, Lei, et al.
Publicado: (2023)

Genomic and transcriptomic profiling indicates the prognosis significance of mutational signature for TMB-high subtype in Chinese patients with gastric cancer
por: Cheng, Yanan, et al.
Publicado: (2022)

Development of an oncogenic dedifferentiation SOX signature with prognostic significance in hepatocellular carcinoma
por: Li, Mei-Mei, et al.
Publicado: (2019)

An Immunogenic Cell Death-Related Gene Signature Reflects Immune Landscape and Predicts Prognosis in Melanoma Independently of BRAF V600E Status
por: Chen, Lizhu, et al.
Publicado: (2023)

Clinical significance and prognostic role of an immune-related gene signature in gastric adenocarcinoma
por: Mao, Rui, et al.
Publicado: (2021)

A Novel Four-Gene Prognostic Signature as a Risk Biomarker in Cervical Cancer
por: Wang, Jun, et al.
Publicado: (2020)

Identification of Immunogenic Cell Death-Related Signature for Glioma to Predict Survival and Response to Immunotherapy
por: Sun, Zhiqiang, et al.
Publicado: (2022)

Immunogenic Cell Death Induced by Ginsenoside Rg3: Significance in Dendritic Cell-based Anti-tumor Immunotherapy
por: Son, Keum-joo, et al.
Publicado: (2016)

The clinical significance of HPIP and the associated prognosis in cervical cancer
por: Meng, Fanling, et al.
Publicado: (2017)

Upregulated Immunogenic Cell-Death-Associated Gene Signature Predicts Reduced Responsiveness to Immune-Checkpoint-Blockade Therapy and Poor Prognosis in High-Grade Gliomas
por: Tang, Xin, et al.
Publicado: (2022)

Systematic profiling of alternative splicing signature reveals prognostic predictor for cervical cancer
por: Hu, Yue-Xin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3iet7v78eb0nrslvdaqic0m5kk